BioMiner: Paving the Way for Personalized Medicine

Personalized medicine is promising a revolution for medicine and human biology in the 21st century. The scientific foundation for this revolution is accomplished by analyzing biological high-throughput data sets from genomics, transcriptomics, proteomics, and metabolomics. Currently, access to these...

Full description

Bibliographic Details
Main Authors: Chris Bauer, Karol Stec, Alexander Glintschert, Kristina Gruden, Christian Schichor, Michal Or-Guil, Joachim Selbig, Johannes Schuchhardt
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Cancer Informatics
Online Access:https://doi.org/10.4137/CIN.S20910
id doaj-1f2d74e6270c45b19ba1461364e80923
record_format Article
spelling doaj-1f2d74e6270c45b19ba1461364e809232020-11-25T03:21:39ZengSAGE PublishingCancer Informatics1176-93512015-01-011410.4137/CIN.S20910BioMiner: Paving the Way for Personalized MedicineChris Bauer0Karol Stec1Alexander Glintschert2Kristina Gruden3Christian Schichor4Michal Or-Guil5Joachim Selbig6Johannes Schuchhardt7Research and Development, MicroDiscovery GmbH, Berlin, Germany.Research and Development, MicroDiscovery GmbH, Berlin, Germany.Research and Development, MicroDiscovery GmbH, Berlin, Germany.Department for Biotechnology and Systems Biology, National Institute of Biology, Ljubljana, Slovenia.Department of Neurosurgery, Klinikum der Ludwig-Maximilian-Universität München, Munich, Germany.Research Center ImmunoSciences, Charité University of Medicine Berlin, Berlin, Germany.Institute of Biochemistry and Biology, University of Potsdam, Potsdam, Germany.Research and Development, MicroDiscovery GmbH, Berlin, Germany.Personalized medicine is promising a revolution for medicine and human biology in the 21st century. The scientific foundation for this revolution is accomplished by analyzing biological high-throughput data sets from genomics, transcriptomics, proteomics, and metabolomics. Currently, access to these data has been limited to either rather simple Web-based tools, which do not grant much insight or analysis by trained specialists, without firsthand involvement of the physician. Here, we present the novel Web-based tool “BioMiner,” which was developed within the scope of an international and interdisciplinary project (SYSTHER † ) and gives access to a variety of high-throughput data sets. It provides the user with convenient tools to analyze complex cross-omics data sets and grants enhanced visualization abilities. BioMiner incorporates transcriptomic and cross-omics high-throughput data sets, with a focus on cancer. A public instance of BioMiner along with the database is available at http://systherDB.microdiscovery.de/ , login and password: “systher”; a tutorial detailing the usage of BioMiner can be found in the Supplementary File.https://doi.org/10.4137/CIN.S20910
collection DOAJ
language English
format Article
sources DOAJ
author Chris Bauer
Karol Stec
Alexander Glintschert
Kristina Gruden
Christian Schichor
Michal Or-Guil
Joachim Selbig
Johannes Schuchhardt
spellingShingle Chris Bauer
Karol Stec
Alexander Glintschert
Kristina Gruden
Christian Schichor
Michal Or-Guil
Joachim Selbig
Johannes Schuchhardt
BioMiner: Paving the Way for Personalized Medicine
Cancer Informatics
author_facet Chris Bauer
Karol Stec
Alexander Glintschert
Kristina Gruden
Christian Schichor
Michal Or-Guil
Joachim Selbig
Johannes Schuchhardt
author_sort Chris Bauer
title BioMiner: Paving the Way for Personalized Medicine
title_short BioMiner: Paving the Way for Personalized Medicine
title_full BioMiner: Paving the Way for Personalized Medicine
title_fullStr BioMiner: Paving the Way for Personalized Medicine
title_full_unstemmed BioMiner: Paving the Way for Personalized Medicine
title_sort biominer: paving the way for personalized medicine
publisher SAGE Publishing
series Cancer Informatics
issn 1176-9351
publishDate 2015-01-01
description Personalized medicine is promising a revolution for medicine and human biology in the 21st century. The scientific foundation for this revolution is accomplished by analyzing biological high-throughput data sets from genomics, transcriptomics, proteomics, and metabolomics. Currently, access to these data has been limited to either rather simple Web-based tools, which do not grant much insight or analysis by trained specialists, without firsthand involvement of the physician. Here, we present the novel Web-based tool “BioMiner,” which was developed within the scope of an international and interdisciplinary project (SYSTHER † ) and gives access to a variety of high-throughput data sets. It provides the user with convenient tools to analyze complex cross-omics data sets and grants enhanced visualization abilities. BioMiner incorporates transcriptomic and cross-omics high-throughput data sets, with a focus on cancer. A public instance of BioMiner along with the database is available at http://systherDB.microdiscovery.de/ , login and password: “systher”; a tutorial detailing the usage of BioMiner can be found in the Supplementary File.
url https://doi.org/10.4137/CIN.S20910
work_keys_str_mv AT chrisbauer biominerpavingthewayforpersonalizedmedicine
AT karolstec biominerpavingthewayforpersonalizedmedicine
AT alexanderglintschert biominerpavingthewayforpersonalizedmedicine
AT kristinagruden biominerpavingthewayforpersonalizedmedicine
AT christianschichor biominerpavingthewayforpersonalizedmedicine
AT michalorguil biominerpavingthewayforpersonalizedmedicine
AT joachimselbig biominerpavingthewayforpersonalizedmedicine
AT johannesschuchhardt biominerpavingthewayforpersonalizedmedicine
_version_ 1724613500539502592